Search

Your search keyword '"IMRE Corp. -- Product information"' showing total 18 results
Start Over Descriptor "IMRE Corp. -- Product information" Publication Year Range Last 50 years
18 results on '"IMRE Corp. -- Product information"'

1. THE JOURNAL TRANSFUSION PUBLISHES ARTICLE ON TREATMENT OF REFRACTORINESS TO PLATELET TRANSFUSION WITH IMRE CORPORATION'S PROSORBA COLUMN

Subjects
IMRE Corp. -- Product information, Biological products industry -- Product information, Pharmaceutical industry -- Product information, Business, News, opinion and commentary
Abstract

SEATTLE, March 18 /PRNewswire/ -- IMRE Corporation (NASDAQ: IMRE), a leader in the field of immunoadsorption, announced today that the journal Transfusion, in its March 1993 issue, reported the treatment [...]

Published
1993

2. CANCER PUBLISHES RESULTS OF TREATMENT OF C-TTP/HUS WITH IMRE CORPORATION'S PROSORBA COLUMN

Subjects
IMRE Corp. -- Product information, Biological products industry -- Product information, Business, News, opinion and commentary
Abstract

SEATTLE, March 16 /PRNewswire/ -- IMRE Corporation (NASDAQ: IMRE), a leader in the field of immunoadsorption, announced today that Cancer, the journal of the American Cancer Society, published data in [...]

Published
1993

3. Imre produces more cancer-related neuropathy data

Subjects
IMRE Corp. -- Product information, Pharmaceutical industry -- Product information, Paraneoplastic syndromes -- Prevention, Peripheral nerve diseases -- Research, Proteins -- Health aspects, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
1995

4. Prosorba cures cancer-related neuropathy

Subjects
IMRE Corp. -- Product information, Pharmaceutical industry -- Product information, Peripheral nerve diseases -- Drug therapy, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
1995

5. IMRE Corp. announces start of new breast cancer and autoimmune disease clinical trials

Subjects
United States. National Cancer Institute -- Public relations, IMRE Corp. -- Product information, Medical equipment and supplies industry -- Product information, Business, Business, general, Prosorba Column (Medical instrument) -- Case studies
Abstract

IMRE CORP. ANNOUNCES START OF NEW BREAST CANCER AND AUTOIMMUNE DISEASE CLINICAL TRIALS SEATTLE, March 12 /PRNewswire/ -- IMRE Corp. (NASDAQ: IMRE) today announced that the company has initiated two [...]

Published
1990

6. Imre's column maintains platelet counts

Subjects
IMRE Corp. -- Product information, Medical equipment and supplies industry -- Product information, Thrombocytopenia -- Care and treatment, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
1993

7. Prosorba column effective in rheumatoid arthritis

Subjects
IMRE Corp. -- Product information, Medical equipment and supplies industry -- Research, Rheumatoid arthritis -- Care and treatment, Immune complexes -- Removal, Business, Health care industry, Pharmaceuticals and cosmetics industries
Published
1992

8. Imre's Prosorba in rheum arthritis

Subjects
IMRE Corp. -- Product information, Pharmaceutical industry -- Product information, Business, Pharmaceuticals and cosmetics industries, Prosorba (Medication) -- Testing
Published
1992

9. US FDA approves lupus trial with Prosorba

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, IMRE Corp. -- Product information, Pharmaceutical industry -- Product information, Lupus erythematosus -- Drug therapy, Business, Pharmaceuticals and cosmetics industries, Prosorba (Medication) -- Testing
Published
1991

10. Trials begin with Prosorba treatment column

Subjects
United States. Food and Drug Administration -- Powers and duties, IMRE Corp. -- Product information, Medical equipment and supplies industry -- Laws, regulations and rules, Business, Health care industry, Pharmaceuticals and cosmetics industries, Prosorba Column (Medical instrument) -- Laws, regulations and rules
Published
1991

12. IMRE gets FDA approval for device

Subjects
United States. Food and Drug Administration -- Management, IMRE Corp. -- Product information, Pharmaceutical industry -- Product information, Kaposi's sarcoma -- Care and treatment, News, opinion and commentary
Published
1987

13. FDA approves IMRE's Prosorba column

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, IMRE Corp. -- Product information, Biotechnology industry -- Product information, Immunoadsorption -- Equipment and supplies, Business, Business, general
Abstract

FDA APPROVES IMRE'S PROSORBA(R) COLUMN SEATTLE, Dec. 24 /PRNewswire/ -- IMRE Corporation (NASDAQ: IMRE) today announced that the Food and Drug Administration (FDA) approved its Prosorba(R) Immunoadsorption Treatment Column for [...]

Published
1987

14. U.S. FDA-approved treatment for AIDS-related disease presented at Fourth International Conference on AIDS

Subjects
IMRE Corp. -- Product information, Medical equipment and supplies industry -- Product information, Hemodialysis -- Equipment and supplies, AIDS (Disease) -- Research, Business, Business, general
Abstract

U.S. FDA-APPROVED TREATMENT FOR AIDS-RELATED DISEASE PRESENTED AT FOURTH INTERNATIONAL CONFERENCE ON AIDS STOCKHOLM, Sweden, June 13 /PRNewswire/ -- Imre' Corporation (NASDAQ: IMRE) today presented clinical findings supporting the new [...]

Published
1988

15. FDA requests additional information on IMRE Corp.'s Prosorba(R) device

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, IMRE Corp. -- Product information, Biotechnology industry -- Product information, Business, Business, general
Abstract

SEATTLE, Nov. 8 /PRNewswire/ -- IMRE Corp. (NASDAQ: IMRE) today announced that the Food and Drug Administration has requested additional information for the company's premarket application of the Prosorba(R) device. [...]

Published
1985

16. IMRE Corp. comments on issuance of patent to Dr. William Bensinger

Subjects
IMRE Corp. -- Product information, Biotechnology industry -- Product information, Business, Business, general
Abstract

SEATTLE, Oct. 10 /PRNewswire/ -- IMRE Corporation announced today it has learned that the U.S. Patent Office has issued a patent to Dr. William Bensinger as inventor (Fred Hutchinson Cancer [...]

Published
1986

17. Advisory panel of Food and Drug Administration recommends pre-market approval application for IMRE Corp.'s prosorba treatment device

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, IMRE Corp. -- Product information, Health care industry -- Product information, Immunologic diseases -- Testing, Business, Business, general
Abstract

NEW YORK, July 30 /PRNewswire/ -- Michael Landes and Albert Schwartz, co-chairmen of the ALMI Group, announced today the sale of certain of their RKO Theatres and Cinema 5 Theatres [...]

Published
1986

18. FDA releases SS&E for IMRE's Prosorba column; IMRE had 1987 loss

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, IMRE Corp. -- Product information, Biotechnology industry -- Product information, Business, Business, general
Abstract

TO BUSINESS DESK AND MEDICAL/SCIENCE EDITORS: FDA RELEASES SS&E FOR IMRE'S PROSORBA COLUMN; IMRE HAD 1987 LOSS SEATTLE, Feb. 25 /PRNewswire/ -- IMRE Corporation (NASDAQ: IMRE) received FDA approval for [...]

Published
1988

Catalog

Books, media, physical & digital resources
See catalog results